Addex Therapeutics (ADXN) EPS (Basic) (2018 - 2026)
Addex Therapeutics (ADXN) posted EPS (Basic) of -$0.0 for Q1 2026, up 100.0% sequentially from -$0.08 in Q4 2025, and down 4.91% YoY from -$0.0 in Q1 2025.
Addex Therapeutics (ADXN) EPS (Basic) (2018 - 2026) Analysis & Trends
Addex Therapeutics has reported EPS (Basic) for 9 years, with the latest figure at -$0.0 in Q1 2026.
- Quarterly EPS (Basic) fell 4.91% year-over-year to -$0.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$0.08 (down 170.82% YoY) and the FY2025 annual result came in at -$0.08, down 194.03% from the prior year.
- EPS (Basic) climbed to -$0.0 in Q1 2026 per ADXN's latest filing, from -$0.08 in the prior quarter.
- Over five years, EPS (Basic) peaked at $0.11 in Q4 2024 and troughed at -$0.08 in Q4 2025.
- A 5-year average of $0.0 and a median of -$0.0 in 2022 frame the typical range for EPS (Basic).
- The sharpest annual moves came in 2022 and 2024: EPS (Basic) plunged 4439497328.56% in 2022, then surged 548.14% in 2024.
- Over 5 years, EPS (Basic) stood at $0.01 in 2022, then surged by 207.82% to $0.02 in 2023, then soared by 548.14% to $0.11 in 2024, then plunged by 170.82% to -$0.08 in 2025, then jumped by 100.0% to -$0.0 in 2026.
- According to Business Quant data, EPS (Basic) over the past three periods registered -$0.0, -$0.08, and -$0.0 for Q1 2026, Q4 2025, and Q3 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Basic) (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 4.34 |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 12.62 |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 7.59 |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | -1.96 |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.23 |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -0.72 |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | -0.06 |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 0.18 |
| 10 | Addex Therapeutics | 534.71 Mn | 534.71 Mn | - | -0.02 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 0.00 |
| Dec 31, 2025 | -0.08 |
| Sep 30, 2025 | 0.00 |
| Jun 30, 2025 | 0.00 |
| Mar 31, 2025 | 0.00 |
| Dec 31, 2024 | 0.11 |
| Sep 30, 2024 | 0.00 |
| Jun 30, 2024 | 0.00 |
| Mar 31, 2024 | 0.00 |
| Dec 31, 2023 | 0.02 |
| Sep 30, 2023 | 0.00 |
| Jun 30, 2023 | 0.00 |
| Dec 31, 2022 | 0.01 |
| Sep 30, 2022 | 0.00 |
| Jun 30, 2022 | -0.01 |
| Mar 31, 2022 | 0.00 |
| Dec 31, 2021 | 0.03 |
| Sep 30, 2021 | 0.00 |
| Jun 30, 2021 | 0.00 |
| Mar 31, 2021 | 0.00 |